ECMO timing study for children with hard-to-treat septic shock
Part of Infections clinical trials.
This trial looks at whether and when a heart-lung machine called ECMO should be used in children whose septic shock is not responding to standard treatment. It may help doctors choose the best timing to improve survival and recovery in the PICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is in the pediatric ICU (PICU) for septic shock
- Your child’s septic shock is not improving despite treatment (refractory septic shock)
- Your child does not have a fatal chromosome condition (for example, trisomy 13 or 18)
- Your child does not have bleeding that cannot be controlled
- Your child does not have irreversible brain damage
- Your child has not had an allogeneic bone marrow transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well antibiotics and other anti-infective drugs work in very sick patients who are on a heart-lung machine called ECMO. If you're in the ICU with a serious infection, this trial could help doctors figure out the best dose for you.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
This study looks at children (ages 1 day to 18 years) in mainland China who were treated with ECMO during the past 10 years. It aims to understand how ECMO was used and how care outcomes may have differed for children.
This study tests a specific heart-lung machine called Cardiohelp to help children with severe heart failure. It looks at how well the machine works and whether a blood thinner (either heparin or bivalirudin) is safer and more effective.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.